Wnt/β-Catenin Signaling Induces Integrin α4β1 in T Cells and Promotes a Progressive Neuroinflammatory Disease in Mice
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
G0701761
Medical Research Council - United Kingdom
PubMed
28939758
DOI
10.4049/jimmunol.1700247
PII: jimmunol.1700247
Knihovny.cz E-resources
- MeSH
- beta Catenin genetics immunology MeSH
- Integrin alpha4beta1 genetics immunology MeSH
- Spinal Cord immunology pathology MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Spinal Cord Diseases genetics immunology pathology MeSH
- Wnt Signaling Pathway genetics immunology MeSH
- Th1 Cells immunology pathology MeSH
- Inflammation genetics immunology pathology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- beta Catenin MeSH
- Integrin alpha4beta1 MeSH
The mechanisms leading to autoimmune and inflammatory diseases in the CNS have not been elucidated. The environmental triggers of the aberrant presence of CD4+ T cells in the CNS are not known. In this article, we report that abnormal β-catenin expression in T cells drives a fatal neuroinflammatory disease in mice that is characterized by CNS infiltration of T cells, glial activation, and progressive loss of motor function. We show that enhanced β-catenin expression in T cells leads to aberrant and Th1-biased T cell activation, enhanced expression of integrin α4β1, and infiltration of activated T cells into the spinal cord, without affecting regulatory T cell function. Importantly, expression of β-catenin in mature naive T cells was sufficient to drive integrin α4β1 expression and CNS migration, whereas pharmacologic inhibition of integrin α4β1 reduced the abnormal T cell presence in the CNS of β-catenin-expressing mice. Together, these results implicate deregulation of the Wnt/β-catenin pathway in CNS inflammation and suggest novel therapeutic strategies for neuroinflammatory disorders.
Central European Institute of Technology Masaryk University Brno 625 00 Czech Republic; and
Department of Medicine University of Perugia Perugia 06132 Italy
Department of Medicine University of Perugia Perugia 06132 Italy;
Mouse Biology Unit European Molecular Biology Laboratory Monterotondo 00015 Italy
Pirogov Russian National Research Medical University 117997 Moscow Russia
References provided by Crossref.org